Company record · OPRX

OptimizeRx Corporation

OptimizeRx Corporation disclosed a change in its chief financial officer, effective January 1, 2027; the incoming officer named in the filing is Mr. D'Silva. Until then the filing lists Edward Stelmakh in the role. See the filing record.

Tracked changes

2026-08-12

OptimizeRx Corporation CFO transition: Mr. D'Silva to succeed Edward Stelmakh

This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.